Latanoprost may be an effective drug in the treatment of eyelash AA because it induces acceptable responses (total and moderate) in 45% of the patients. A formal, blinded prospective unilateral controlled study will permit further understanding about this promising therapeutic agent for eyelash AA.

No abstract

No abstract

In conclusion, in our groups, statistically significant elevations of serum PSA levels were observed in women with clinical signs of hyperandrogenism. We found higher levels in ovarian and adrenal subtypes, whereas women without clinical hyperandrogenism or women with clinical hyperandrogenism and normal hormonal serum levels had lower PSA levels.Although more studies and wider sample groups are needed, it seems that PSA determination is a good clinical hyperandrogenism marker and could be used in the monitoring of anti-androgenic treatment.

No abstract

No abstract

No abstract

No abstract